Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00304174 · ClinicalTrials.gov registry record
Motivating Factors That Play a Role in Bulimia Nervosa
A clinical trial, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- 90
- Enrollment target
NCT00304174: Completed study, sponsored by New York State Psychiatric Institute.
NCT00304174 is a clinical trial that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00304174 has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
This study will evaluate whether people with bulimia nervosa will binge eat in a structured laboratory setting and display behavioral patterns similar to those of individuals who are dependent on drugs.
Interventions
- BEHAVIORAL Motivation to eat
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2005-05 |
| Est. Completion | 2016-05 |
What the finished NCT00304174 record still lists
NCT00304174 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Motivation to eat is the first listed.
NCT00304174 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00304174 about?
NCT00304174 is a clinical study titled "Motivating Factors That Play a Role in Bulimia Nervosa". This study will evaluate whether people with bulimia nervosa will binge eat in a structured laboratory setting and display behavioral patterns similar to those of individuals who are dependent on drugs.
What is the current status of trial NCT00304174?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2005-05. Estimated completion is 2016-05.
What interventions are being tested in trial NCT00304174?
The interventions under investigation include: Motivation to eat (BEHAVIORAL).
Who is sponsoring clinical trial NCT00304174?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia